FPR2 and Alzheimer disease: We sought to determine the potential of Fpr2/3 as a target to control Aβ-driven inflammation earlier in the disease process when oligomeric Aβ is found in the nanomolar range [30], hence we characterised the inflammatory response of BV2 cells to AD-relevant concentrations of Aβ.